Related references
Note: Only part of the references are listed.Calcium Signaling in Systemic Lupus Erythematosus T Cells A Treatment Target
Vasileios C. Kyttaris et al.
ARTHRITIS AND RHEUMATISM (2011)
Suppression of Autoimmunity and Organ Pathology in Lupus-Prone Mice Upon Inhibition of Calcium/Calmodulin-Dependent Protein Kinase Type IV
Kunihiro Ichinose et al.
ARTHRITIS AND RHEUMATISM (2011)
Pregnancy Outcomes in Patients with Autoimmune Diseases and Anti-Ro/SSA Antibodies
Antonio Brucato et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2011)
In Situ B Cell-Mediated Immune Responses and Tubulointerstitial Inflammation in Human Lupus Nephritis
Anthony Chang et al.
JOURNAL OF IMMUNOLOGY (2011)
Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial
Sandra V. Navarra et al.
LANCET (2011)
A systemic lupus erythematosus gene expression array in disease diagnosis and classification: a preliminary report
Y-T Juang et al.
LUPUS (2011)
Chromatin as a target antigen in human and murine lupus nephritis
Annica Hedberg et al.
ARTHRITIS RESEARCH & THERAPY (2011)
Fc gamma RIIB, Fc gamma RIIIB, and systemic lupus erythematosus
Heather A. Niederer et al.
YEAR IN IMMUNOLOGY 2 (2010)
A decade of mycophenolate mofetil for lupus nephritis: is the glass half-empty or half-full?
Dimitrios T. Boumpas et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
The Efficacy and Safety of Abatacept in Patients With Non-Life-Threatening Manifestations of Systemic Lupus Erythematosus Results of a Twelve-Month, Multicenter, Exploratory, Phase IIb, Randomized, Double-Blind, Placebo-Controlled Trial
J. T. Merrill et al.
ARTHRITIS AND RHEUMATISM (2010)
Targeted Tumor Necrosis Factor Receptor I Preligand Assembly Domain Improves Skin Lesions in MRL/lpr Mice
Guo-Min Deng et al.
ARTHRITIS AND RHEUMATISM (2010)
Efficacy and Safety of Rituximab in Moderately-to-Severely Active Systemic Lupus Erythematosus The Randomized, Double-Blind, Phase II/III Systemic Lupus Erythematosus Evaluation of Rituximab Trial
Joan T. Merrill et al.
ARTHRITIS AND RHEUMATISM (2010)
Lupus Serum IgG Induces Skin Inflammation through the TNFR1 Signaling Pathway
Guo-Min Deng et al.
JOURNAL OF IMMUNOLOGY (2010)
Mycophenolate mofetil and intravenous cyclophosphamide are similar as induction therapy for class V lupus nephritis
Jai Radhakrishnan et al.
KIDNEY INTERNATIONAL (2010)
Antiphospholipid syndrome
Guillermo Ruiz-Irastorza et al.
LANCET (2010)
Functionally defective germline variants of sialic acid acetylesterase in autoimmunity
Ira Surolia et al.
NATURE (2010)
Understanding the Epidemiology and Progression of Systemic Lupus Erythematosus
Guillermo J. Pons-Estel et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2010)
Pathogenesis of human systemic lupus erythematosus: recent advances
Jose C. Crispin et al.
TRENDS IN MOLECULAR MEDICINE (2010)
Atherosclerotic Vascular Events in a Multinational Inception Cohort of Systemic Lupus Erythematosus
M. B. Urowitz et al.
ARTHRITIS CARE & RESEARCH (2010)
A Retrospective Seven-Year Analysis of the Use of B Cell Depletion Therapy in Systemic Lupus Erythematosus at University College London Hospital: The First Fifty Patients
Tim Y-T. Lu et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2009)
Mechanisms of Immune Complex-Mediated Neutrophil Recruitment and Tissue Injury
Tanya N. Mayadas et al.
CIRCULATION (2009)
Fcγ receptors: structure, function and role as genetic risk factors in SLE
X. Li et al.
GENES AND IMMUNITY (2009)
Recent insights into the genetic basis of systemic lupus erythematosus
K. L. Moser et al.
GENES AND IMMUNITY (2009)
Kallikrein genes are associated with lupus and glomerular basement membrane-specific antibody-induced nephritis in mice and humans
Kui Liu et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
The Role of IL-23/IL-17 Axis in Lupus Nephritis
Zheng Zhang et al.
JOURNAL OF IMMUNOLOGY (2009)
Activation of Mammalian Target of Rapamycin Controls the Loss of TCRζ in Lupus T Cells through HRES-1/Rab4-Regulated Lysosomal Degradation
David R. Fernandez et al.
JOURNAL OF IMMUNOLOGY (2009)
Exposure to maternal smoking and incident SLE in a prospective cohort study
J. F. Simard et al.
LUPUS (2009)
Rituximab in systemic lupus erythematosus A systematic review of off-label use in 188 cases
M. Ramos-Casals et al.
LUPUS (2009)
Finding the missing heritability of complex diseases
Teri A. Manolio et al.
NATURE (2009)
A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus
Vesela Gateva et al.
NATURE GENETICS (2009)
Neurotoxic autoantibodies mediate congenital cortical impairment of offspring in maternal lupus
Ji Y. Lee et al.
NATURE MEDICINE (2009)
Phenotypic Characterization of Autoreactive B Cells - Checkpoints of B Cell Tolerance in Patients with Systemic Lupus Erythematosus
Annett M. Jacobi et al.
PLOS ONE (2009)
Relationship between anti-dsDNA, anti-nucleosome and anti-alpha-actinin antibodies and markers of renal disease in patients with lupus nephritis: a prospective longitudinal study
Jessica J. Manson et al.
ARTHRITIS RESEARCH & THERAPY (2009)
Advances in the diagnosis and therapy of paroxysmal nocturnal hemoglobinuria
Robert A. Brodsky
BLOOD REVIEWS (2008)
A role for sex chromosome complement in the female bias in autoimmune disease
Deborah L. Smith-Bouvier et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Cholera toxin B accelerates disease progression in lupus-prone mice by promoting lipid raft aggregation
Guo-Min Deng et al.
JOURNAL OF IMMUNOLOGY (2008)
Expanded Double Negative T Cells in Patients with Systemic Lupus Erythematosus Produce IL-17 and Infiltrate the Kidneys
Jose C. Crispin et al.
JOURNAL OF IMMUNOLOGY (2008)
Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX
Geoffrey Hom et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Complement receptors CD21 and CD35 in humoral immunity
Ramon Roozendaal et al.
IMMUNOLOGICAL REVIEWS (2007)
Variation in the relative copy number of the TLR7 gene in patients with systemic lupus erythematosus and healthy control subjects
James Kelley et al.
ARTHRITIS AND RHEUMATISM (2007)
Anti-alpha-actinin antibodies: A new marker of lupus nephritis
Yves Renaudineau et al.
AUTOIMMUNITY REVIEWS (2007)
Expression profile of FcγRIIB on leusocytes and its dysregulation in systemic lupus erythematosus
Kaihong Su et al.
JOURNAL OF IMMUNOLOGY (2007)
Phosphorylated ERM is responsible for increased T cell polarization, adhesion, and migration in patients with systemic lupus erythematosus
Yansong Li et al.
JOURNAL OF IMMUNOLOGY (2007)
Clinical manifestations and coronary artery disease risk factors at diagnosis of systemic lupus erythematosus: data from an international inception cohort
M. B. Urowitz et al.
LUPUS (2007)
Human lupus autoantibodies against NMDA receptors mediate cognitive impairment
Czeslawa Kowal et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
The transcriptional repressor cAMP response element modulator α interacts with histone deacetylase 1 to repress promoter activity
Klaus Tenbrock et al.
JOURNAL OF IMMUNOLOGY (2006)
Persistent expression of autoantibodies in SLE patients in remission
Sergey Yurasov et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Selective dysregulation of the FcγIIB receptor on memory B cells in SLE
Meggan Mackay et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus
Xuebing Feng et al.
ARTHRITIS AND RHEUMATISM (2006)
The epigenetic face of systemic lupus erythematosus
E Ballestar et al.
JOURNAL OF IMMUNOLOGY (2006)
Epstein-Barr virus and molecular mimicry in systemic lupus erythematosus
BD Poole et al.
AUTOIMMUNITY (2006)
Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant
T Vang et al.
NATURE GENETICS (2005)
Protein phosphatase 2A is a negative regulator of IL-2 production in patients with systemic lupus erythematosus
CG Katsiari et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Systemic lupus erythematosus serum IgG increases CREM binding to the IL-2 promoter and suppresses IL-2 production through CaMKIV
YT Juang et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Nucleosome, the main autoantigen in systemic lupus erythematosus, induces direct dendritic cell activation via a MyD88-independent pathway:: Consequences on inflammation
P Decker et al.
JOURNAL OF IMMUNOLOGY (2005)
Human lupus T cells resist inactivation and escape death by upregulating COX-2
LT Xu et al.
NATURE MEDICINE (2004)
Sequential therapies for proliferative lupus nephritis
G Contreras et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Defective control of latent Epstein-Barr virus infection in systemic lupus erythematosus
I Kang et al.
JOURNAL OF IMMUNOLOGY (2004)
B cell depletion as a novel treatment for systemic lupus erythematosus - A phase I/II dose-escalation trial of rituximab
RJ Looney et al.
ARTHRITIS AND RHEUMATISM (2004)
Genetic models for the clearance of apoptotic cells
PL Cohen et al.
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2004)
Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation
G Girardi et al.
NATURE MEDICINE (2004)
The role of complement in the development of systemic lupus erythematosus
AP Manderson et al.
ANNUAL REVIEW OF IMMUNOLOGY (2004)
Endothelial cell apoptosis in systemic lupus erythematosus: a common pathway for abnormal vascular function and thrombosis propensity
S Rajagopalan et al.
BLOOD (2004)
Interferon and granulopoiesis signatures in systemic lupus erythematosus blood
L Bennett et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
LJP 394 for the prevention of renal flare in patients with systemic lupus erythematosus -: Results from a randomized, double-blind, placebo-controlled study
D Alarcón-Segovia et al.
ARTHRITIS AND RHEUMATISM (2003)
Dehydroepiandrosterone treatment of women with mild-to-moderate systemic lupus erythematosus - A multicenter randomized, double-blind, placebo-controlled trial
DM Chang et al.
ARTHRITIS AND RHEUMATISM (2002)
Steroid hormones and disease activity during pregnancy in systemic lupus erythematosus
A Doria et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2002)
Induction of dendritic cell differentiation by IFN-α in systemic lupus erythematosus
P Blanco et al.
SCIENCE (2001)
Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis
GG Illei et al.
ANNALS OF INTERNAL MEDICINE (2001)
Plasmacytoid dendritic cells (natural interferon-α/β-producing cells) accumulate in cutaneous lupus erythematosus lesions
L Farkas et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Genetic, structural and functional diversities of human complement components C4A and C4B and their mouse homologues, Slp and C4
CA Blanchong et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2001)
Molecular aberrations in human systemic lupus erythematosus
GC Tsokos et al.
MOLECULAR MEDICINE TODAY (2000)
Increased excretions of β2-microglobulin, IL-6, and IL-8 and decreased excretion of Tamm-Horsfall glycoprotein in urine of patients with active lupus nephritis
CY Tsai et al.
NEPHRON (2000)
Share Paper
